Effect of beta-glucans on an ETEC infection in piglets.

[1]  L. Duchateau,et al.  Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection. , 2007, Veterinary microbiology.

[2]  Siamon Gordon,et al.  C‐type lectin‐like receptors on myeloid cells , 2006, Annals of medicine.

[3]  J. Kalbfleisch,et al.  Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge , 2005, Journal of Pharmacology and Experimental Therapeutics.

[4]  N. Markova,et al.  Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. , 2005, International immunopharmacology.

[5]  M. Vrvić,et al.  Natural and Modified (1→3)-β-D-Glucans in Health Promotion and Disease Alleviation , 2005 .

[6]  E. Cox,et al.  Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. , 2004, Vaccine.

[7]  J. Remon,et al.  Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. , 2003, Veterinary immunology and immunopathology.

[8]  Houng-Yung Chen,et al.  Dietary β-1,3-glucan effectively improves immunity and survival of Penaeus monodon challenged with white spot syndrome virus , 2003 .

[9]  E. Cox,et al.  Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides. , 2003, Vaccine.

[10]  E. Cox,et al.  Antigen dose modulates the immunoglobulin isotype responses of pigs against intramuscularly administered F4-fimbriae. , 2002, Veterinary immunology and immunopathology.

[11]  L. Duchateau,et al.  Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain. , 2002, Vaccine.

[12]  J. Kalbfleisch,et al.  Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor kappaB activation and interleukin 8 production. Winner of the Best Paper Award from the Gold Medal Forum. , 2002, The American surgeon.

[13]  N. Ohno,et al.  Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice. , 2000, FEMS immunology and medical microbiology.

[14]  W. Van den Broeck,et al.  Receptor-specific binding of purified F4 to isolated villi. , 1999, Veterinary microbiology.

[15]  W. Van den Broeck,et al.  Induction of immune responses in pigs following oral administration of purified F4 fimbriae. , 1999, Vaccine.

[16]  W. Van den Broeck,et al.  Receptor-Dependent Immune Responses in Pigs after Oral Immunization with F4 Fimbriae , 1999, Infection and Immunity.

[17]  Y. Adachi,et al.  Signal transduction pathway on beta-glucans-triggered hydrogen peroxide production by murine peritoneal macrophages in vitro. , 1996, Biological & pharmaceutical bulletin.

[18]  F. Blecha,et al.  Influence of dietary beta-glucan on growth performance, nonspecific immunity, and resistance to Streptococcus suis infection in weanling pigs. , 1995, Journal of animal science.

[19]  Y. Adachi,et al.  Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. , 1995, Biological & pharmaceutical bulletin.

[20]  Y. Adachi,et al.  Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice. , 1995, Biological & pharmaceutical bulletin.

[21]  Y. Adachi,et al.  Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. , 1994, Biological & pharmaceutical bulletin.

[22]  C. Gyles.  Escherichia coli in Domestic Animals and Humans , 1994 .

[23]  Y. Adachi,et al.  Application of limulus test (G pathway) for the detection of different conformers of (1-->3)-beta-D-glucans. , 1993, Biological & pharmaceutical bulletin.

[24]  J. Raa,et al.  Enhancement of non-specific disease resistance in Atlantic salmon, Salmo salar L.; by a glucan from Saccharomyces cerevisiae cell walls. , 1990 .

[25]  Y. Maeda,et al.  Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses. , 1988, Cancer research.

[26]  P. Deprez,et al.  The influence of the administration of sow's milk on the postweaning excretion of hemolyticE. coli in the pig , 1986, Veterinary Research Communications.

[27]  T. W. Holbrook,et al.  Visceral leishmaniasis in mice: protective effect of glucan. , 1980, Journal of the Reticuloendothelial Society.

[28]  D. Williams,et al.  Glucan-induced modification of murine viral hepatitis. , 1980, Science.

[29]  J. Cook,et al.  Protective effect of glucan in experimentally induced candidiasis. , 1978, Journal of the Reticuloendothelial Society.

[30]  J. Cook,et al.  Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. , 1978, Science.

[31]  D. Manners,et al.  Isolation and composition of an alkali-soluble glucan from the cell walls of Saccharomyces cerevisiae. , 1976, Journal of general microbiology.

[32]  G. Jones,et al.  Protection against Enteric Disease caused by Escherichia coli–a Model for Vaccination with a Virulence Determinant? , 1973, Nature.

[33]  G. Chihara,et al.  The significance of the higher structure of the polysaccharides lentinan and pachymaran with regard to their antitumour activity. , 1971, Chemico-biological interactions.

[34]  V. Vetvicka,et al.  Pilot Study: Orally-Administered Yeast β1,3-glucan Prophylactically Protects Against Anthrax Infection and Cancer in Mice , 2002 .

[35]  J. Raa.  The use of immunostimulatory substances in fish and shellfish farming , 1996 .

[36]  James N. BeMiller,et al.  (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships , 1995 .

[37]  J. Osek,et al.  Evaluation of different vaccines to control of pig colibacillosis under large-scale farm conditions. , 1995, Comparative immunology, microbiology and infectious diseases.

[38]  T. Yadomae,et al.  Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells. , 1991, International journal of immunopharmacology.

[39]  T. Yadomae,et al.  Effect of orally administered β-glucan on macrophage function in mice , 1990 .

[40]  N. Ohno,et al.  Immunomodulation by orally administered β-glucan in mice , 1989 .

[41]  D. Williams,et al.  Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis. , 1988, The Journal of surgical research.

[42]  D. Williams,et al.  Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. , 1987, International journal of immunopharmacology.

[43]  T. Newby,et al.  The Immune Response Following Oral Vaccination with E. coli , 1981 .